Injectable Lysis Therapies and Their Implications in Critical Care

This chapter explores injectable lysis therapies for empyema, referencing important trials like MIST-2 and PICOLO that showcase their effectiveness. It also addresses risks such as bleeding, critiques the lack of ICU representation in research, and underscores the importance of concurrent antibiotic treatment.